Showing 2 posts of 2 posts found.
Cizzle Biotechnology has launched the commercial rollout of its CIZ1B Biomarker Blood Test for lung cancer in Texas in the …
A blood test that costs less than £50 to perform could prevent men from undergoing treatment with two drugs that …
Lonza and Engitix partner to develop next-generation antibody-drug conjugates
Simris Group appoints Tiffany J Vora as Strategic Advisor
Cizzle Biotechnology expands US rollout of lung cancer blood test
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide